SCHEMBL30898119

SCHEMBL30898119

COC(=O)/C=C/CN1CCC2(CCNC2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.50
▸ KDM1A O60341 2/20 0.38
▸ MAOB P27338 1/20 0.38
▸ RCOR1 Q9UKL0 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.35
▸ PDCD1LG2 Q9BQ51 2/20 0.35
▸ CD274 Q9NZQ7 2/20 0.35
▸ CYP2D6 P10635 5/20 0.34
▸ CYP3A4 P08684 4/20 0.34
▸ CYP1A2 P05177 2/20 0.33
▸ NAMPT P43490 1/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ L3MBTL3 Q96JM7 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ USP2 O75604 1/20 0.32
▸ TNF P01375 1/20 0.31
▸ ESR1 P03372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30898063 0.92 KDM1A (0.44) TSHRKDM1AMAOBRCOR1ALDH1A1
SCHEMBL30898026 0.92 TSHR (0.42) TSHRKDM1AMAOBRCOR1ALDH1A1
SCHEMBL30898078 0.91 TSHR (0.37) TSHRKDM1AMAOBRCOR1ALDH1A1
SCHEMBL30898029 0.87 CYP1A2 (0.41) TSHRKDM1AMAOBRCOR1ALDH1A1
SCHEMBL30898092 0.85 CYP2D6 (0.35) TSHRCYP2D6TNF
SCHEMBL30898035 0.82 HCAR2 (0.36) TNF
SCHEMBL31335868 0.75 HCAR2 (0.35) CYP2D6TNF
SCHEMBL2463453 0.72 TSHR (0.61) TSHRKDM1AMAOBRCOR1ALDH1A1
SCHEMBL30335554 0.72 CYP2C9 (0.50) TSHRALDH1A1CYP2D6CYP3A4CYP1A2
SCHEMBL19992731 0.70 TSHR (0.58) TSHRKDM1AMAOBRCOR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024083086-A1 BICYCLIC DERIVATIVE INTEGRIN INHIBITOR 上海如凌生物医药有限公司 2024-04-25 — — WO disclosed
Send feedback